Steve Stadum was Fred Hutch’s chief operating officer from 2016 until January 2022, when he assumed the role of chief integration officer, leading a newly developed Integration Management Office.
In this role, he works in close partnership with leadership from Fred Hutch, Seattle Cancer Care Alliance and UW Medicine to complete the Oncology Restructure transaction and plan for Fred Hutch and SCCA integration.
“His in-depth knowledge of the structure of all four organizations and his aptitude for building trusting relationships, empowering leaders and managing successfully through complexity are just a few of the stellar qualities that make him the best person to lead us through this important integration work,” said Fred Hutch President and Director and Raisbeck Endowed Chair holder Dr. Thomas J. Lynch when Stadum’s role was announced in 2021.
As chief integration officer, Stadum focuses on the steps required to successfully merge Fred Hutch and SCCA and prepare both organizations to launch the new Fred Hutchinson Cancer Center. These integration efforts include preparing to unify the people, processes, policies and systems at Fred Hutch and SCCA as well as the clinical integration of cancer care at both the UW Medicine and SCCA locations.
In his previous role at the Hutch, Stadum was responsible for all operational activities of the research center, which has a 16-acre campus and employs more than 3,000. He also played a central role in relations between Fred Hutch and its SCCA partners.